Consensus document on controversial issues for the treatment of hospital-associated pneumonia

Antonio Cascio, Francesco N. Lauria, Mauro Moroni, Giampiero Carosi, Matteo Bassetti, Francesco Blasi, Fabio Franzetti, Emanuele Nicastri, Francesco Scaglione, Massimo Antonelli, Giuseppe Ippolito, Martin Langer

Risultato della ricerca: Article

6 Citazioni (Scopus)

Abstract

Background: Hospital-associated pneumonia (HAP) remains an important cause of morbidity andmortality despite advances in antimicrobial therapy. Many aspects of the treatment of HAP caused bymulti-resistant Gram-positive microorganisms have been extensively studied, but controversial issuesremain.Controversial issues: The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group– a panel of multidisciplinary experts – was to define recommendations for some controversial issuesusing an evidence-based and analytical approach. The controversial issues were: (1) Is combinationantibiotic therapy or monotherapy more effective in the treatment of HAP? (2) What role dopharmacokinetic/pharmacodynamic antibiotic features have as a guide in the selection of treatment forHAP? (3) Is a de-escalation approach for the management of HAP effective? An analysis of the studiespublished up until April 2009 is presented and discussed in detail.Methods: A systematic literature search using PubMed, MEDLINE, and EMBASE databases and theCochrane Library was performed. A matrix was created to extract evidence from original studies usingthe CONSORT method to evaluate randomized clinical trials and the Newcastle–Ottawa QualityAssessment Scale for case–control studies, longitudinal cohorts, and retrospective studies. The GRADEmethod for grading quality of evidence was applied. 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved
Lingua originaleEnglish
pagine (da-a)S55-S65
Numero di pagine16
RivistaInternational Journal of Infectious Diseases
Volume14
Stato di pubblicazionePublished - 2010

Fingerprint

Pneumonia
PubMed
MEDLINE
Libraries
Longitudinal Studies
Cohort Studies
Randomized Controlled Trials
Retrospective Studies
Databases
Anti-Bacterial Agents
Morbidity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cita questo

Cascio, A., Lauria, F. N., Moroni, M., Carosi, G., Bassetti, M., Blasi, F., ... Langer, M. (2010). Consensus document on controversial issues for the treatment of hospital-associated pneumonia. International Journal of Infectious Diseases, 14, S55-S65.

Consensus document on controversial issues for the treatment of hospital-associated pneumonia. / Cascio, Antonio; Lauria, Francesco N.; Moroni, Mauro; Carosi, Giampiero; Bassetti, Matteo; Blasi, Francesco; Franzetti, Fabio; Nicastri, Emanuele; Scaglione, Francesco; Antonelli, Massimo; Ippolito, Giuseppe; Langer, Martin.

In: International Journal of Infectious Diseases, Vol. 14, 2010, pag. S55-S65.

Risultato della ricerca: Article

Cascio, A, Lauria, FN, Moroni, M, Carosi, G, Bassetti, M, Blasi, F, Franzetti, F, Nicastri, E, Scaglione, F, Antonelli, M, Ippolito, G & Langer, M 2010, 'Consensus document on controversial issues for the treatment of hospital-associated pneumonia', International Journal of Infectious Diseases, vol. 14, pagg. S55-S65.
Cascio, Antonio ; Lauria, Francesco N. ; Moroni, Mauro ; Carosi, Giampiero ; Bassetti, Matteo ; Blasi, Francesco ; Franzetti, Fabio ; Nicastri, Emanuele ; Scaglione, Francesco ; Antonelli, Massimo ; Ippolito, Giuseppe ; Langer, Martin. / Consensus document on controversial issues for the treatment of hospital-associated pneumonia. In: International Journal of Infectious Diseases. 2010 ; Vol. 14. pagg. S55-S65.
@article{af8f4292e5014473bc5c16acbafd7e9c,
title = "Consensus document on controversial issues for the treatment of hospital-associated pneumonia",
abstract = "Background: Hospital-associated pneumonia (HAP) remains an important cause of morbidity andmortality despite advances in antimicrobial therapy. Many aspects of the treatment of HAP caused bymulti-resistant Gram-positive microorganisms have been extensively studied, but controversial issuesremain.Controversial issues: The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group– a panel of multidisciplinary experts – was to define recommendations for some controversial issuesusing an evidence-based and analytical approach. The controversial issues were: (1) Is combinationantibiotic therapy or monotherapy more effective in the treatment of HAP? (2) What role dopharmacokinetic/pharmacodynamic antibiotic features have as a guide in the selection of treatment forHAP? (3) Is a de-escalation approach for the management of HAP effective? An analysis of the studiespublished up until April 2009 is presented and discussed in detail.Methods: A systematic literature search using PubMed, MEDLINE, and EMBASE databases and theCochrane Library was performed. A matrix was created to extract evidence from original studies usingthe CONSORT method to evaluate randomized clinical trials and the Newcastle–Ottawa QualityAssessment Scale for case–control studies, longitudinal cohorts, and retrospective studies. The GRADEmethod for grading quality of evidence was applied. 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved",
author = "Antonio Cascio and Lauria, {Francesco N.} and Mauro Moroni and Giampiero Carosi and Matteo Bassetti and Francesco Blasi and Fabio Franzetti and Emanuele Nicastri and Francesco Scaglione and Massimo Antonelli and Giuseppe Ippolito and Martin Langer",
year = "2010",
language = "English",
volume = "14",
pages = "S55--S65",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Consensus document on controversial issues for the treatment of hospital-associated pneumonia

AU - Cascio, Antonio

AU - Lauria, Francesco N.

AU - Moroni, Mauro

AU - Carosi, Giampiero

AU - Bassetti, Matteo

AU - Blasi, Francesco

AU - Franzetti, Fabio

AU - Nicastri, Emanuele

AU - Scaglione, Francesco

AU - Antonelli, Massimo

AU - Ippolito, Giuseppe

AU - Langer, Martin

PY - 2010

Y1 - 2010

N2 - Background: Hospital-associated pneumonia (HAP) remains an important cause of morbidity andmortality despite advances in antimicrobial therapy. Many aspects of the treatment of HAP caused bymulti-resistant Gram-positive microorganisms have been extensively studied, but controversial issuesremain.Controversial issues: The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group– a panel of multidisciplinary experts – was to define recommendations for some controversial issuesusing an evidence-based and analytical approach. The controversial issues were: (1) Is combinationantibiotic therapy or monotherapy more effective in the treatment of HAP? (2) What role dopharmacokinetic/pharmacodynamic antibiotic features have as a guide in the selection of treatment forHAP? (3) Is a de-escalation approach for the management of HAP effective? An analysis of the studiespublished up until April 2009 is presented and discussed in detail.Methods: A systematic literature search using PubMed, MEDLINE, and EMBASE databases and theCochrane Library was performed. A matrix was created to extract evidence from original studies usingthe CONSORT method to evaluate randomized clinical trials and the Newcastle–Ottawa QualityAssessment Scale for case–control studies, longitudinal cohorts, and retrospective studies. The GRADEmethod for grading quality of evidence was applied. 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved

AB - Background: Hospital-associated pneumonia (HAP) remains an important cause of morbidity andmortality despite advances in antimicrobial therapy. Many aspects of the treatment of HAP caused bymulti-resistant Gram-positive microorganisms have been extensively studied, but controversial issuesremain.Controversial issues: The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group– a panel of multidisciplinary experts – was to define recommendations for some controversial issuesusing an evidence-based and analytical approach. The controversial issues were: (1) Is combinationantibiotic therapy or monotherapy more effective in the treatment of HAP? (2) What role dopharmacokinetic/pharmacodynamic antibiotic features have as a guide in the selection of treatment forHAP? (3) Is a de-escalation approach for the management of HAP effective? An analysis of the studiespublished up until April 2009 is presented and discussed in detail.Methods: A systematic literature search using PubMed, MEDLINE, and EMBASE databases and theCochrane Library was performed. A matrix was created to extract evidence from original studies usingthe CONSORT method to evaluate randomized clinical trials and the Newcastle–Ottawa QualityAssessment Scale for case–control studies, longitudinal cohorts, and retrospective studies. The GRADEmethod for grading quality of evidence was applied. 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved

UR - http://hdl.handle.net/10447/379939

M3 - Article

VL - 14

SP - S55-S65

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -